[Research on pharmacodynamic reinforcement of neuroleptics by the 1035 M.D].
D000328:Adult; D002746:Chlorpromazine / Q000627:therapeutic use; D004357:Drug Synergism; D006801:Humans; D008607:Intellectual Disability / Q000188:drug therapy; D001523:Mental Disorders / Q000188:drug therapy*; D008728:Methotrimeprazine / Q000627:therapeutic use; D008875:Middle Aged; D010640:Phenothiazines / Q000627:therapeutic use; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000188:drug therapy; D013881:Thioridazine / Q000627:therapeutic use; D014149:Tranquilizing Agents / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000627:therapeutic use*
D010640:Phenothiazines; D014149:Tranquilizing Agents; D014665:Vasodilator Agents; D008728:Methotrimeprazine; D013881:Thioridazine; D002746:Chlorpromazine
Recherche d'un renforcement pharmacodynamique des neuroleptiques par le 1035 M.D.